Evidence map›Paper›PMID 36033540›Full record

SynthesisFrontiers in oncology2022

Sex-related disparities in outcomes of cholangiocarcinoma patients in treatment trials.

Matthew Ledenko, Samuel O Antwi, Shiho Arima, Julia Driscoll, Junji Furuse, Heinz-Josef Klümpen, Finn Ole Larsen, David K Lau, Annett Maderer, Alice Markussen and 10 more

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Sexual dimorphism in the liver.Nature reviews. Gastroenterology & hepatology · 2026
    Review
  2. Article
  3. Sex-related disparities in outcomes of survival in biliary tract cancer patients.Journal of cancer research and clinical oncology · 2025
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Matthew LedenkoDepartment of Transplantation, Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, United States.
Samuel O AntwiDepartment of Quantitative Health Sciences, Mayo Clinic, Jacksonville, FL, United States.
Shiho ArimaDepartment of Digestive and Lifestyle Diseases, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Julia DriscollDepartment of Transplantation, Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, United States.
Junji FuruseDepartment of Medical Oncology, Kyorin University Faculty of Medicine, Tokyo, Japan.
Heinz-Josef KlümpenDepartment of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Center (UMC), Amsterdam, Netherlands.
Finn Ole LarsenDepartment of Oncology, Copenhagen University Hospital, Herlev and Gentofte Hospital, Herlev, Denmark.
David K LauOncogenic Transcription Laboratory, Olivia Newton-John Cancer and Research Institute, Melbourne, VIC, Australia.
Annett MadererFirst Department of Medicine, University Medical Center of the Johannes-Gutenberg University, Mainz, Germany.
Alice MarkussenDepartment of Oncology, Copenhagen University Hospital, Herlev and Gentofte Hospital, Herlev, Denmark.
Markus MoehlerFirst Department of Medicine, University Medical Center of the Johannes-Gutenberg University, Mainz, Germany.
Lynn E NooijenDepartment of Surgery, Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, Netherlands.
Walid L ShaibDepartment of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, United States.
Niall C TebbuttDepartment of Medical Oncology, Olivia Newton-John Cancer Centre at Austin Health, Heidelberg, VIC, Australia.
Thierry AndréSorbonne University and Department of Medical Oncology, Hôpital Saint-Antoine, AP-HP, Paris, France.
Makoto UenoDepartment of Gastroenterology, Hepatobiliary and Pancreatic Medical Oncology Division, Kanagawa Cancer Center, Kanagawa, Japan.
Rachel WoodfordNational Health and Medical Research Council Clinical Trials Centre (NHMRC CTC), Medical Foundation Building, University of Sydney, Camperdown, NSW, Australia.
Changhoon YooDepartment of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Mark M ZalupskiDepartment of Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI, United States.
Tushar PatelDepartment of Transplantation, Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biliary cancerschemotherapygemcitabinesurvivaltherapeutic response

Identifiers

PMID36033540
PMCPMC9404243

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.